Entra Pharmaceuticals, a Waltham, MA-based drug delivery startup, raised $4.2 million in the first tranche of a Series A venture financing, according to PE Hub, which cited a regulatory filing. The round could be expanded to $12.5 million by the end of November if Entra reaches certain milestones. Flybridge Capital Partners and North Bridge Venture Partners are backing the company.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
